Philip Rosenfeld
Professor of Ophthalmology · University of Miami/Jackson Health System
Credentials: · · · ·
History
- 1992–1993
- 1988–1989
Preliminary or Transitional Year
- 1984–1988
Research
Ranibizumab for neovascular age-related macular degeneration
New England Journal of Medicine · 2006 · First of 8 authors · Corresponding · 4,838 citations
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication
Cell · 1987 · 965 citations
The Lancet · 2015 · 934 citations
40 papers
39 papers
33 papers
32 papers
- JL
29 papers · 23 as a resident
24 papers
19 papers
- CP
18 papers
Clinical trials
- 2010–2011
Principal investigator · Completed
Carl Zeiss Meditec, Inc.
- 2009–2013
Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
Principal investigator · Completed · Phase 2
Philip J. Rosenfeld, MD, PhD
- 2004–2007
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
Principal investigator · Completed · Phase 2
University of Miami
- 2004–2007
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
Principal investigator · Completed · Phase 2
University of Miami